Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

403 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A Word to the Wise About Intranasal Esketamine.
Schatzberg AF. Schatzberg AF. Am J Psychiatry. 2019 Jun 1;176(6):422-424. doi: 10.1176/appi.ajp.2019.19040423. Epub 2019 May 21. Am J Psychiatry. 2019. PMID: 31109197 No abstract available.
Pharmacogenetics of antidepressant medication intolerance.
Murphy GM Jr, Kremer C, Rodrigues HE, Schatzberg AF. Murphy GM Jr, et al. Among authors: schatzberg af. Am J Psychiatry. 2003 Oct;160(10):1830-5. doi: 10.1176/appi.ajp.160.10.1830. Am J Psychiatry. 2003. PMID: 14514498 Clinical Trial.
A word to the wise about ketamine.
Schatzberg AF. Schatzberg AF. Am J Psychiatry. 2014 Mar;171(3):262-4. doi: 10.1176/appi.ajp.2014.13101434. Am J Psychiatry. 2014. PMID: 24585328 No abstract available.
Opioids in Psychiatric Disorders: Back to the Future?
Schatzberg AF. Schatzberg AF. Am J Psychiatry. 2016 Jun 1;173(6):564-5. doi: 10.1176/appi.ajp.2015.15101354. Epub 2015 Dec 18. Am J Psychiatry. 2016. PMID: 26684924 No abstract available.
Antidepressant Outcomes Predicted by Genetic Variation in Corticotropin-Releasing Hormone Binding Protein.
O'Connell CP, Goldstein-Piekarski AN, Nemeroff CB, Schatzberg AF, Debattista C, Carrillo-Roa T, Binder EB, Dunlop BW, Craighead WE, Mayberg HS, Williams LM. O'Connell CP, et al. Among authors: schatzberg af. Am J Psychiatry. 2018 Mar 1;175(3):251-261. doi: 10.1176/appi.ajp.2017.17020172. Epub 2017 Dec 15. Am J Psychiatry. 2018. PMID: 29241359 Free PMC article. Clinical Trial.
Attenuation of Antidepressant Effects of Ketamine by Opioid Receptor Antagonism.
Williams NR, Heifets BD, Blasey C, Sudheimer K, Pannu J, Pankow H, Hawkins J, Birnbaum J, Lyons DM, Rodriguez CI, Schatzberg AF. Williams NR, et al. Among authors: schatzberg af. Am J Psychiatry. 2018 Dec 1;175(12):1205-1215. doi: 10.1176/appi.ajp.2018.18020138. Epub 2018 Aug 29. Am J Psychiatry. 2018. PMID: 30153752 Free PMC article. Clinical Trial.
Double-blind, placebo-controlled, dose-ranging trial of intravenous ketamine as adjunctive therapy in treatment-resistant depression (TRD).
Fava M, Freeman MP, Flynn M, Judge H, Hoeppner BB, Cusin C, Ionescu DF, Mathew SJ, Chang LC, Iosifescu DV, Murrough J, Debattista C, Schatzberg AF, Trivedi MH, Jha MK, Sanacora G, Wilkinson ST, Papakostas GI. Fava M, et al. Among authors: schatzberg af. Mol Psychiatry. 2020 Jul;25(7):1592-1603. doi: 10.1038/s41380-018-0256-5. Epub 2018 Oct 3. Mol Psychiatry. 2020. PMID: 30283029 Free PMC article.
403 results